Gabelli Funds »

Apellis Pharmaceuticals shares owned by Gabelli Funds

Quarter-by-quarter ownership of Apellis Pharmaceuticals shares owned by Gabelli Funds from 13F filings

Historical chart of Gabelli Funds investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Gabelli Funds consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Gabelli Funds

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 321k 40.23

More positions owned by Gabelli Funds

Newmont Corp Equity (NEM)
Nvidia Corp Equity (NVDA)
National Fuel Gas Equity (NFG)
Ametek Equity (AME)
Microsoft Corp Equity (MSFT)
Nextera Energy Equity (NEE)
Mastercard Inc - A Equity (MA)
Bank Of New York Mellon Corp Equity (BNY)
Gatx Corp Equity (GATX)
Deere & Co Equity (DE)
Mueller Industries Equity (MLI)
American Express Equity (AXP)
Amazon.com Equity (AMZN)
Madison Square Garden Sports Equity (MSGS)
Crane Equity (CR)

View all positions for Gabelli Funds

Top funds holding Apellis Pharmaceuticals

BlackRock
venBio Select Advisor
Morgan Stanley
State Street Corporation
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
Deep Track Capital
Point72 Asset Management
Rtw Investments
HBK Investments
Suvretta Capital Management
Millennium Management
Geode Capital Management

View all funds holding Apellis Pharmaceuticals